Summary
Edwards Lifesciences Corporation (EW) announced significant management changes through an 8-K filing on December 14, 2005, effective January 1, 2006. The most notable change is the appointment of Corinne H. Lyle, currently Corporate Vice President, Chief Financial Officer and Treasurer, to the position of President, Global Operations. Ms. Lyle's extensive background includes experience in finance, investor relations, strategic planning, and business development from her prior roles at Tularik, Inc. and investment banking firms. Complementing these changes, Thomas M. Abate, currently Corporate Vice President and Controller, will assume the role of Corporate Vice President, Chief Financial Officer and Treasurer. Mr. Abate brings considerable experience within Edwards Lifesciences, including spearheading Sarbanes-Oxley compliance, managing tax and treasury, and playing a key role in the company's spin-off from Baxter International. These strategic appointments reflect a focus on internal leadership development and continuity in critical financial and operational roles.
Key Highlights
- 1Corinne H. Lyle appointed President, Global Operations, effective January 1, 2006.
- 2Thomas M. Abate appointed Corporate Vice President, Chief Financial Officer and Treasurer, effective January 1, 2006.
- 3The changes represent an internal promotion for both Ms. Lyle and Mr. Abate.
- 4Ms. Lyle brings a strong financial and strategic background from previous roles at Tularik and in investment banking.
- 5Mr. Abate has significant experience within Edwards Lifesciences, including Sarbanes-Oxley implementation and the company's spin-off from Baxter.
- 6The filing includes a press release dated December 14, 2005, detailing these management changes as Exhibit 99.1.